MicroRNAs Potentiate Neural Development  by Fineberg, Sarah K. et al.
Neuron
Minireview
MicroRNAs Potentiate Neural Development
Sarah K. Fineberg,1,4 Kenneth S. Kosik,5 and Beverly L. Davidson1,2,3,*
1Department of Molecular Physiology and Biophysics
2Department of Internal Medicine
3Department of Neurology
4Medical Scientist Training Program
University of Iowa, Iowa City, IA 52242 USA
5Neuroscience Research Institute, University of California, Santa Barbara, Santa Barbara, CA 93106-5060, USA
*Correspondence: beverly-davidson@uiowa.edu
DOI 10.1016/j.neuron.2009.10.020
MicroRNAs (miRNAs) are endogenously expressed noncoding RNAs that regulate mRNA expression. In
vertebrates, more distinct miRNAs are expressed in the brain than in any other tissue, where they are hypoth-
esized to function in neural development. Recent reports describing the effects of specific miRNAs during
development, and studies employing miRNA depletion as neural commitment proceeds in the embryo,
support a requisite role for miRNAs in cell-fate decisions and provide clues to their function in other aspects
of nervous system development.MicroRNAs are small noncoding RNAs that regulate gene
expression in a variety of organisms by base pairing to mRNAs.
miRNA expression is enriched in the nervous system (Krichevsky
et al., 2003; Miska et al., 2004; Sempere et al., 2004; Wienholds
et al., 2005), and distinct miRNA expression profiles are seen in
germ cells, neural stem cells, and fetal brain (Kloosterman et al.,
2006a; Wienholds et al., 2005), with levels changing dramatically
upon neuronal differentiation (reviewed in Gangaraju and Lin,
2009). Recent studies have helped clarify the role of miRNAs in
neural development. Together the data support the hypothesis
that miRNAs influence cell differentiation and/or cell cycling in
the developing CNS and may contribute to neurodevelopmental
diseases. While the focus of this review is onmiRNAs, it is impor-
tant to note that other species of noncoding RNAs have func-
tional importance in neural cells, including small nucleolar
RNAs (snoRNAs) (Cavaille et al., 2000), small cytoplasmic RNAs
(Tiedge et al., 1993), and endogenous small interfering RNAs
(endo-siRNAs) (Carlile et al., 2009).
miRNA Biogenesis
miRNA transcription occurs via RNA polymerase II or RNA poly-
merase III, upstream of intergenic miRNAs or miRNAs residing in
introns of coding or noncoding genes (reviewed in Liu et al., 2008)
(Figure 1). For many miRNAs, the primary transcript (pri-miRNA)
is processed in the nucleus by Drosha/DGCR8 to liberate an
70 nt pre-miRNA product that is then exported into the cyto-
plasm by exportin V. Some miRNAs encoded in introns can
bypass nuclear processing (mirtrons) prior to export (Berezikov
et al., 2007; Ruby et al., 2007). The cytoplasmic RNase Dicer
further processes the pre-miRNA into a 21–22 nt duplex, and
one or both strands is then loaded into theAgo-protein-containing
complex called theRNA induced silencing complex (RISC).Within
RISC, the single-stranded mature miRNA forms partial comple-
mentary contacts on target mRNAs, which typically mediate
mRNA degradation or translational inhibition.
miRNAs can be controlled posttranscriptionally by several
pathways. For example, in embryonic stem cells, Lin28 inhibits
let-7 maturation, but in neural stem cells, Lin28 is downregulatedand let-7 processing proceeds (Newman et al., 2008; Rybak
et al., 2008; Viswanathan et al., 2008). In some cell types, inhibi-
tion of processing occurs through Lin28-mediated recruitment of
an uridyl transferase (Heo et al., 2008). Following uridylation, pre-
let-7 fails to proceed to Dicer processing and is degraded.
Alteration of the pri-miRNA sequence by the action of Adeno-
sineDeaminase Acting on double strandedRNA (ADAR) enzymes
can also affect miRNA processing (Kawahara et al., 2007a, 2008;
Luciano et al., 2004; Yang et al., 2006) or alter the mRNAs they
target (Kawahara et al., 2007b). The consequence of ADAR
activity is the conversion of adenosine (A) to inosine (I). Because
I is read as guanine for base pairing, consequencesmight include
changes in stem-loop stability as well as changes in target mRNA
selection.A to I editingofpri-miRNAswasdemonstrated in human
andmouse brain samples (Kawahara et al., 2007a). Given that the
brain shows enriched ADAR activity compared to other tissues,
editing-induced functional changes tomiRNAsorcreationofnovel
miRNA target sites in 30 UTRs of mRNAs (Borchert et al., 2009)
may facilitate expression of brain-specific genetic programs.
Some miRNAs have upstream RE1 silencing transcription
factor (REST) elements that can repress their expression in non-
neuronal cells and neural progenitor cells (reviewed in Ballas and
Mandel, 2005). Interestingly, several of the miRNAs whose levels
are controlled by REST target mRNAs that encode components
of the REST repressor complexes, including REST, CoREST,
MeCP2, and SCP1 (Conaco et al., 2006; Klein et al., 2007;
Packer et al., 2008; Visvanathan et al., 2007). If REST inhibits
the expression of miRNAs, what induces their expression?While
not fully understood, Vo et al. showed that the transcription
factor CREB occupies elements upstream of miR-132, suggest-
ing that it may promote miRNA expression (Vo et al., 2005).
There are antisense transcripts nearby and/or overlapping
with miRNAs that can give rise to another miRNA that, in the
case of Drosophila, serves to regulate genes within the same
family as the sense-encoded miRNA (Stark et al., 2008a; Tyler
et al., 2008). Transcripts antisense to miRNAs could possibly
regulate the activity of the sense miRNA through competitive
binding, similar to artificial ‘‘sponge’’ sequences sequesteringNeuron 64, November 12, 2009 ª2009 Elsevier Inc. 303
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Deep sequencing efforts to quantify the relative levels of these
transcripts and the effects of loss of function of the antisense
sequences will help define their role.
miRNA Function in Early Neurogenesis
While an absolute requirement for miRNAs in the initiation of
neurulation has not been reported, they are plausible players.
Dicer null zebrafishundergonervoussystemdifferentiation (Giral-
dez et al., 2005), but they have prominent morphological nervous
systemdefects.WhenDicer is deleted in thedevelopingmamma-
lian nervous system, gross histological aberrations, and in some
cases embryonic lethality, occur (Choi et al., 2008; Cuellar et al.,
2008; Damiani et al., 2008; Davis et al., 2008b; De Pietri Tonelli
et al., 2008; Kim et al., 2007; Stark et al., 2008b). While these
studies support a strict requirement for Dicer in neural develop-
ment, these phenotypes may not be due solely to miRNA deple-
tion; Dicer is required for the maturation of some snoRNAs (Taft
et al., 2009) and endo-siRNAs (Golden et al., 2008). And while
a reduction of abundant brain-enriched miRNAs (e.g., miR-9
andmiR-124) has been reported inDicer null embryos, it is doubt-
ful that all mature miRNAs are affected. Indeed, one challenge of
studies utilizing conditional, cell-type-specific dicer ablation is
determining exactly when and which miRNAs are lost. miRNA
half life in vivo could be highly variable, and functional effects
could persist days after Dicer inactivation (Davis et al., 2008b).
Finally, Dicer depletion could elevate pri-miRNAs and pre-
miRNAs, impacting cell division and differentiation in a manner
independent from loss of mature miRNA(s) (Stark et al., 2008b).
To refine our understanding of the role of miRNAs in develop-
ment, investigators have assessed how specific miRNAs impact
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Figure 1. miRNA Biogenesis and Processing
(A) MiRNAs are expressed as pri-miRNAs or mirtrons as de-
picted. Pri-miRNAs are processed by Drosha/DGCR8 in the
nucleus to pre-miRNAs prior to cytoplasmic export by expor-
tin V. The pri-miR is shown encoding a single miRNA, but pri-
miRNAs encoding several miRNAs are common. Intronic
miRNA expression can be controlled from host gene
promoters, or internal promoters (Ozsolak et al., 2008). Once
in the cytoplasm, pre-miRNAs are further processed by
Dicer/TRBP to form a 21–22 nt duplex. Association of the
duplex with an argonaut protein complex forms the RISC,
which can mediate inhibition of mRNA expression.
(B) miRNA levels can be controlled by transcription (e.g.,
promoter activity) or processing. Inhibition of processing can
occur via blockage of Drosha processing in the nucleus (e.g.,
by ADAR activity [Yang et al., 2006]), export, or Dicer process-
ing in the cytoplasm (e.g., by uridinylation [Rybak et al., 2008]).
Inhibition of activity could also be controlled by sequestration
of the miRNA, impeding miRNA:mRNA interaction.
protein complexes with defined functions. One early
example of miRNAs’ importance in cell-fate deci-
sions is the elegant description of left-right asymme-
try decisions in C. elegans sensory neurons (Chang
et al., 2004; Johnston and Hobert, 2003). More
recently, Slack and colleagues found that loss of
the let-7 target gene, Mlin41, causes neural tube
defects, indicating a role for miRNAs in neural tube
closure in mouse (Maller Schulman et al., 2008).
Other target proteins required for neural tubeclosure
may be under miRNA control. For example, miR-9* and miR-124
inhibit the neural progenitor cell specific BAF53a and BAF45a,
reducing proliferation and inducing differentiation (Yoo et al.,
2009). One could envision that other miRNAs might also inhibit
expression of the prodifferentiation homologs of these proteins,
BAF53b and BAF45b. An imbalance of miRNAs controlling these
opposing complexes could shift developmental transitions
between progenitor cells and their differentiated phenotypes.
The interplay between miRNAs and development extends
beyonddirectmiRNA targets. For example,miR-124 also impacts
neuronal gene expression broadly by reducing the expression of
the splicing regulator, PTBP1 (Makeyev et al., 2007). Because
PTBP1 induces nonsense-mediated decay of PTBP2, an impor-
tant neuronal cell splicing regulator, the loss of PTBP1 stabilizes
PTBP2, thus increasing its proneuronal splicing activity.
miRNAs in Cortical Development
miRNAs play a role in cortical neogenesis (Tables 1 and 2). Two
recent studies assessed the consequences of Dicer depletion in
olfactory progenitor cells at approximately embryonic day 9.5
(E9.5), a point which closely coincides with olfactory neogenesis.
Choi et al. noted a reduced number of neuron-committed
progenitor cells and mature neurons (Choi et al., 2008), while
Makeyev et al. observed disorganization throughout the cortex,
ectopic expression of PTBP1, and loss of the postmitotic post-
migratory marker MAP2 (Makeyev et al., 2007). Apoptosis was
increased, but the studies did not include a detailed analysis of
progenitor cell pools or their proliferation. miRNAs also play a
role in progenitor cell maintenance and differentiation and
neocortex formation (De Pietri Tonelli et al., 2008). Deletion of
Dicer in the developing cerebral cortex by E9.5 led to the304 Neuron 64, November 12, 2009 ª2009 Elsevier Inc.
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aFoxg1-Cre;
DicerloxP/loxP
bEmx-1-Cre X
DicerloxP/loxP
cMicrodeletion
Syntenic to Human
22q11.2
dRag1AG-Cre (a-CamKII
Promoter);DicerloxP/loxP
eChx10-
Cre;DicerloxP/loxP
Location/time of
enzyme loss
E9.5 concurrent
with olfactory
neurogenesis
From E9.5 in
the dorsal
telencephalon
Presuming all
tissues, timing
unknown. Genetic
deletion of DGCR8-
containing region;
(deletes other
genes in the region)
creates model
haploinsufficient for
DGCR8.
From E15.5 in cortex and
hippocampus
Mosaic expression
in developing retina
at P16
Confirmed time of
miR loss
E13.5 miR200a is
reduced from
olfactory epithelium
E10.5 Pri-miRs rise, but
19% of mature
miRs expressed in
prefrontal cortex
and 10% of miRs
expressed in
hippocampus are
reduced
For miR132 14%–20%
loss at P15, 60% by P21
No change atP30,
but strong
decreases in
several miRNAs at
3 and 7 months
Survival Death in utero To weaning Normal in
hemizygous
deletion
Homozygotes die early
postnatal (40% by P2,
100% by P20)
Normal
Patterning Defined regions of
olfactory structure
are present
Normal Normal Normal
Brain size Small forebrain and
eyes
Small forebrain Normal with
DGCR8
haploinsufficiency
Small forebrain and
reduced brain mass at P21
Cell loss Loss of olfactory
markers by E10.5,
profound by E16.5
In emerging lamina
by E12.5, later in
proliferative regions
Not directly measured, but
enlarged lateral ventricles
and smaller cortex
Extensive retinal
degeneration
Apoptosis Present by E10.5,
persistent at E12.5
Present by E12.5,
widespread by
E14.5
Apoptotic cells near VZ at
P0, limited apoptotic signal
at P15
Extensive cell loss
from 3 months on
Histopath At E10.5, no gross
change in olfactory
pits, but 18%
neuron loss. At
E13.5, marked
thinning with loss of
olfactory neuron
markers.
Decreased
proliferation
affects SVZ > VZ,
present by E14.5.
Reduced cortical
thickness and
disorganization.
In hippocampus,
decrease in
dendrite
complexity, spine
number and size
Decreased dendritic
branching and increased
apical dendritic spine length
in hippocampus at P21
Rosette formation
at P16, then
progressive
remodeling of
retinal lamina
between P16 and
P45
Cortical layers Distinct cortical
layers fail to form
Normal
Behavior Hyperactive, but
more fearful of
novelty. Reduced
performance on
fear-context task
and spatial memory
task.
At P14, tremors, ataxia,
unison hindlimb movement,
clasping
ERG amplitudes
decreased in
homozygous and
heterozygous
animals
aChoi et al., 2008.
bDe Pietri Tonelli et al., 2008.
c Stark et al., 2008b.
dDavis et al., 2008b.
eDamiani et al., 2008.Neuron 64, November 12, 2009 ª2009 Elsevier Inc. 305
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miRNA Function Targets Regulation Reference
let-7 Neural tube closure Mlin41 Maller Schulman et al., 2008
miR-9 Promotes NPC differentiation
in mouse cortex, maintains
organizer activity at midbrain-
hindbrain boundary in zebrafish
TLX, REST, Fgf8, FGFR1 RE1 sites in promoters block
nonneural transcription
Conaco et al., 2006;
Packer et al., 2008;
Shibata et al., 2008;
Zhao et al., 2009
miR-9* BAF53a, BAF45a, CoREST As miR-9 Yoo et al., 2009;
Packer et al., 2008
miR-10 Control of zebrafish branchial
nerve migration
HoxB1a, HoxB3a Woltering and Durston,
2008
miR-17 Blocks neural differentiation Repressed by retinoic acid Beveridge et al., 2009
miR-34 Cell cycle genes, predicted
to target Notch pathway,
Wnt pathway, Math1
p53, CREB
miR-124 Promotes neuronal
transcriptome
BAF53a, BAF45a, SCP1,
PTBP1, Sox9
RE1 sites in promoters block
nonneural transcription
Yoo et al., 2009;
Conaco et al., 2006;
Visvanathan et al., 2007;
Makeyev et al., 2007;
Cheng et al., 2009
miR-125 May promote cerebellar
granule cell differentiation
Smo, Gli Ferretti et al., 2008
miR-132 MeCP2 RE1 sites in promoters block
nonneural transcription;
CREB induces transcription
Conaco et al., 2006;
Klein et al., 2007;
Vo et al., 2005
miR-324-5p May promote cerebellar
granule cell differentiation
Smo, Gli Ferretti et al., 2008
miR-326 May promote cerebellar
granule cell differentiation
Smo, Gli Ferretti et al., 2008reduction of some specificmiRNAs by E10.5. By E12.5, the cere-
bral cortex was thinned, and there was increased apoptosis in
newborn neurons. Animals were microcephalic and failed to
thrive past P24–P25. Interestingly, assessment at E13.5 revealed
no impact of miRNA depletion on apical progenitors in the
ventricular zone and basal progenitors in the subventricular
zone. By E14.5, however, there was depletion of mitotic apical
and basal progenitor cells. Thus, loss of miRNAs in neural
progenitor cells early in corticogenesis profoundly impacts
production of neurons and subsequently decreases progenitor
cell renewal. The extent to which loss of progenitor cells is due
to altered asymmetric divisions, precocious neuronal differentia-
tion, or apoptosis is unclear. Also unclear is whether these
defects reflect loss of many miRNAs or a select few.
In the cortical hem (a narrow strip of tissue in the developing
forebrain that lies between the emerging choroid plexus and
the more rostral neural tissue), miR-9 promotes the differentia-
tion of NPCs and impacts progenitor cell pools (Shibata et al.,
2008). Overexpression of miR-9 at E11.5 but not E14.5 caused
ectopic production and location of Cajal-Retzius neurons,
implying that miR-9-overexpressing progenitor cells, which
consequently possess reduced levels of the miR-9 target
FoxG1, differentiate prematurely and cause disorganization.
Similar results are seen with another miR-9 target, TLX, a nuclear
receptor essential for neural stem cell self-renewal (Zhao et al.,
2009). Overexpression of miR-9 at E13.5 reduces TLX levels,
leading to inappropriate migration and premature differentiation.306 Neuron 64, November 12, 2009 ª2009 Elsevier Inc.Depleting miRNA pools later in cortical development is also
detrimental. Mice with Dicer loss at E15.5 in postmitotic excit-
atory forebrain neurons have microcephaly, alterations in hippo-
campal neuron spine density and branching, and ataxia by P15
(Davis et al., 2008b). Fifty percent of the mice die by postnatal
day 10, and none survive beyond weaning. In contrast to Dicer
depletion at E9, there is no effect on cortical lamination, despite
a progressive decline in miR-124 and miR-132.
miRNA depletion also affects the adult neurogenesis niche.
Work from the Doetsch lab found that miR-124 modulates the
transitory progression of adult neurogenesis within the subven-
tricular zone (SVZ) by influencing expression of the transcription
factor Sox 9 (Cheng et al., 2009). Increased levels of Sox 9 main-
tained purified SVZ stem cells as dividing precursors, while
ectopic expression of miR-124 led to precocious and increased
neuron formation.
Hindbrain Development Requires miRNAs
The rhombomeres of the hindbrain play a crucial role in cerebellar
differentiation and brainstem patterning. The nested expression
of the Hox gene cluster in rhombomeres is well established, but
recent work has revealed an additional level of regulation. This
cluster also harbors miRNAs that regulate the Hox genes and
noncoding RNAs that overlap and probably help restrict Hox
gene expression patterns (reviewed in Lund, 2009). For example,
miR-10 regulates HoxB1a and HoxB3a in zebrafish, and loss of
that control impairs migration of branchial nerves (Woltering
and Durston, 2008). Another critical factor for appropriate
Neuron
Minireviewhindbraindevelopment is Fgf8 (reviewed inSatoet al., 2004). Fgf8
and its downstream signals are prime candidates for miRNA-
mediated regulation because the strength of the Fgf8 signal
determines differentiation into the mesencephalonic or the
more caudal rhombomere1. Interestingly, Leucht and colleagues
found thatmiR-9 targets Fgf8 and its receptor, Fgfr1, in the zebra-
fish midbrain-hindbrain boundary (Leucht et al., 2008).
In the developing cerebellum, granule cell differentiation is
induced by production of sonic hedgehog (Shh) by Purkinje cells.
Several interactionsbetweenmiRNAsand thehedgehogpathway
have been shown in fly (Friggi-Grelin et al., 2008). Also, recent
work has demonstrated increased levels of miRs-125, -324-5p,
and 326 during cerebellar development in humans (Ferretti
et al., 2008). These miRNAs repress the Shh pathway members
Smoothened and Gli in human medulloblastoma cell lines, indi-
cating roles in prodifferentiation signaling pathways during cere-
bellar development. The developing cerebellum also requires
secretion of BMP, Wnt1, and retinoic acid (RA) by the roof plate
of the fourth ventricle. Interestingly, the miR-34 family of miRNAs
ispredicted to targetWnt1andMath1, abHLH transcription factor
expressed in the rhombic lip. BMP signals through Smads, which
can control miRNA levels by direct induction of transcription or by
promoting pri-miRNA processing (Davis et al., 2008a). As in the
Shh pathway, miRNAs regulate BMP/SMAD signaling to repress
proliferation and tissue growth. A link between RA and miRNAs
has also been shown, as the miR-17 cluster is repressed by RA
in human neuroblasts, causing derepression of genes important
for differentiation (Beveridge et al., 2009).
miRNA Levels Vary in Neurodevelopmental Disorders
It is not surprising that this class of regulators has been linked to
developmental disorders. Indeed, miRNAs are dysregulated in
theprefrontal cortexof schizophrenicandschizoaffectivepatients
(Perkins et al., 2007). Mature miR-181b is elevated in samples
from the auditory cortex, thought to be the anatomical substrate
of auditory hallucinations in schizophrenia, in schizophrenic
patients relative tocontrols (Beveridgeetal., 2008). Twopredicted
targets of miR-181b are visinin-like 1, a calcium sensor gene, and
the glutamate receptor subunit GRIA2, both of which were
decreased in patient brains. Other work found that mice with
a chromosomal deletion syntenic to microdeletions found in indi-
viduals at high risk for schizophrenia had haploinsuffiency in
DCGR8 (Starket al., 2008b) (Table1).ReducedDCGR8, acompo-
nent of themicroprocessor complex important formiRNAmatura-
tion, would appear incongruous with the elevated miRNA levels
found in patient brain samples by Beveridge and colleagues.
However, miRNAs embedded within short introns can bypass
nuclear processing (Berezikov et al., 2007; Ruby et al., 2007).
miRNAdysfunctionmaycontribute toautismspectrumdisorder
(ASD),as microdeletionsorduplicationsat15q13.2q13.3,a region
encoding at least one miRNA, can cause phenotypes with ASD
features (Miller et al., 2008). Additional studies on patient tissues
confirm that miRNAs are not globally dysregulated, although
several were expressed at different levels in autistic samples
(Abu-Elneel et al., 2008). Interestingly, neurexin and SHANK3,
genes with known genetic links to autism, are among the pre-
dicted targets of the putatively dysregulated miRNAs.
Rett syndrome is a neurodevelopmental disorder resulting
from loss of function of MeCP2, which becomes apparent intoddlers and progresses with spastic movements, epilepsy,
and loss of motor and communicative skills. MeCP2 expression
increases transcription of the cortical trophic factor BDNF, which
promotes transcription of miR-132. However, MeCP2 is also
a target of miR-132. In differentiated neural tissue, MeCP2 tran-
scripts harbor long 30 UTRswith active miR-132 sites, in contrast
to MeCP2 transcripts in other tissues, which have short 30 UTRs
that lackmiR-132 binding sites (Klein et al., 2007). Thus, miR-132
acts to decrease its own production, which may ‘‘protect’’ the
cell against fluctuating MeCP2 levels.
Tourette’s syndrome is a genetically influenced developmental
neuropsychiatric disorder which may be linked to the gene en-
coding Slit and Trk-like 1 (SLITRK1). In patient samples, Abelson
et al. found a frameshift mutation in SLITRK1 and a variant in the
binding site formiRNAhsa-miR-189 in the SLITRK1 30 UTR (Abel-
son et al., 2005). The consequenceof themutation in the 30 UTR is
enhanced miR-189 repression, suggesting a rare genetic basis
for Tourette’s syndrome that may be driven by a miRNA.
Fragile X syndrome is a common cause of mental retardation
and results from loss of function of FMRP1. The FMRP1 protein
has been shown to interact with the RISC components ARGO-
NAUTE (AGO) and DICER inDrosophila andmammalian cell lines
(Jin et al., 2004), suggesting a link with the miRNA pathway.
Further, FMRP1 is located in P bodies and cytoplasmic granules,
whichare thought tobe the locationofmiRNA-mediated transcript
repression.WhileFMRP1 isassociatedwith themiRNAmachinery
and can directly bind and repress mRNA targets, it is not known
whether small RNAs play a role (reviewed in Li et al., 2008).
miRNAs may also participate in environmentally induced neu-
rodevelopmental disorders. For example, Sathyan et al. found
that ethanol exposure induced changes in expression levels of
miRNAs postulated tomodulate cell damage responses in neural
progenitor cells (Sathyan et al., 2007). It is almost certain that the
number of disorders in whichmiRNAs participate will increase as
our abilities to query miRNA function and miRNA-mRNA interac-
tions become more sophisticated.
Conclusions
Until recently, the hypotheseswe formed aboutmiRNAs in neural
development were based on very focused and difficult to gener-
alize models and by analogies to other organ systems. However,
the rapid development of the miRNA field has clarified their func-
tions at key steps. One clear role that has emerged for miRNAs is
to facilitate the coordinated transitions in the proteome that
temper stem cell renewal and promote neuronal differentiation.
Future investigations are likely to reinforce their importance in
development and disease in neural and nonneural systems.
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